| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/10/2008 | WO2007037886B1 Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear |
| 01/10/2008 | US20080009463 Method of treating dry eye disease with purinergic receptor agonists |
| 01/10/2008 | US20080009042 separating the yeast from the culture medium to yield an albumin solution; subjecting the albumin solution to positive mode cation exchange, affinity, and positive mode anion exchange chromatography; and concentrating and formulating the albumin with sodium octanoate and sodium chloride |
| 01/10/2008 | US20080008756 Homogenous Solid Matrix Containing Vegetable Protein |
| 01/10/2008 | US20080008742 Chewy products and methods for making the same |
| 01/10/2008 | US20080008741 Methods of Treating Irritable Bowel Syndrome |
| 01/10/2008 | US20080008726 Vaccine Composition Against Rhodococcus Equi |
| 01/10/2008 | US20080008723 comprising a conserved di-glucosyl -tri-heptosyl inner-core moiety ; Actinobacillus pleuropneumoniae (Ap), Mannheimia haemolytica (Mh) and Pasteurella multocida (Pm); toxoids |
| 01/10/2008 | US20080008709 Conjugation of biomolecules using Diels-Alder cycloaddition |
| 01/10/2008 | US20080008659 Oral dosage form comprising an antimisuse system |
| 01/10/2008 | DE19933492B4 Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung A conjugate for placement of a cell, or membrane compartment-specific transport of active substances, a process for its preparation and its use |
| 01/10/2008 | DE102006031175A1 Wässrige Arzneimittelformulierung von 4-[((4-Carboxybutyl)-(2[(4-phenethyl-benzyl)oxy]-phenethyl)amino)methyl]benzoesäur An aqueous pharmaceutical formulation of 4 - [((4-carboxybutyl) - (2 [(4-phenethyl-benzyl) oxy] phenethyl) amino) methyl] benzoesäur |
| 01/10/2008 | DE10015463B4 Creme in Form einer überwässerten Wasser-in-Öl-Emulsion Cream in the form of a überwässerten water-in-oil emulsion |
| 01/10/2008 | CA2706124A1 Nanoparticles for nucleic acid delivery |
| 01/10/2008 | CA2656992A1 Immunotoxins for the treatment of diseases related to cmv infection |
| 01/10/2008 | CA2656903A1 An oral pharmaceutical composition of anilinopyrimidine, preparation and use thereof |
| 01/10/2008 | CA2656630A1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoic acid |
| 01/10/2008 | CA2656332A1 Metal-containing formulations and methods of use |
| 01/10/2008 | CA2655188A1 New protein conjugates and methods for their preparation |
| 01/10/2008 | CA2655164A1 Delivery device having self-assembling dendritic polymers and method of use thereof |
| 01/10/2008 | CA2654902A1 Solid compositions comprising tadalafil and at least one carrier |
| 01/10/2008 | CA2654668A1 Two step miniemulsion process |
| 01/10/2008 | CA2654383A1 Pharmaceutical compositions of ropinirole and methods of use thereof |
| 01/10/2008 | CA2648520A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 01/09/2008 | EP1876188A1 Two step miniemulsion process |
| 01/09/2008 | EP1875926A1 Stable emulsion composition |
| 01/09/2008 | EP1875914A1 Solid compositions comprising tadalafil and at least one carrier |
| 01/09/2008 | EP1875913A1 Compositions and method for treating infection in cattle and swine |
| 01/09/2008 | EP1875911A1 Stabilized composition |
| 01/09/2008 | EP1875905A2 Pharmaceutical compound in the form of a hydrogel for transdermal application of active substances |
| 01/09/2008 | EP1875901A1 Propofol-containing fat emulsion |
| 01/09/2008 | EP1875898A2 Transdermal patch for administering fentanyl |
| 01/09/2008 | EP1874844A1 Hyperbranched polymers and their applications |
| 01/09/2008 | EP1874797A1 Method of preparing grafted polylysine dendrimers |
| 01/09/2008 | EP1874729A1 Biodegradable polyphosphazenes containing pyrrolidone side groups |
| 01/09/2008 | EP1874357A1 Pharmaceutical dosage forms comprising a lipid phase |
| 01/09/2008 | EP1874352A2 Photodynamic therapy using chemoluminescence and a ligand-photosensitiser conjugate |
| 01/09/2008 | EP1874343A2 Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease |
| 01/09/2008 | EP1874277A1 Sustained release l-arginine formulations and methods of manufacture and use |
| 01/09/2008 | EP1587843A4 Combinatorial libraries of monomer domains |
| 01/09/2008 | EP1446118B1 Oral dosage form of parecoxib |
| 01/09/2008 | EP1399531B1 Methods and formulations for enhancing the dissolution of a solid material in liquid |
| 01/09/2008 | EP1377183B1 Cactaceae-based formulation having the property of fixing fats, and method for obtaining same |
| 01/09/2008 | EP1315729B1 Compounds in the form of homodimeric or heterodimeric prodrugs; process for obtaining these prodrugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterases-mediated diseases or dysfunction |
| 01/09/2008 | EP1135463B1 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 01/09/2008 | EP1129064B1 Transfection reagents |
| 01/09/2008 | EP1011729B1 Oligonucleotides which specifically bind retroviral nucleocapsid proteins |
| 01/09/2008 | EP0970227B1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/09/2008 | CN101103045A 修饰的Fc分子 Modified Fc molecule |
| 01/09/2008 | CN101102797A 外用组合物 Topical compositions |
| 01/09/2008 | CN101102796A Benzothiazole formulations and use thereof |
| 01/09/2008 | CN101102795A Drug carrier and drug carrier kit for inhibiting fibrosis |
| 01/09/2008 | CN101102774A Intravenous formulations of PDE-5 inhibitors |
| 01/09/2008 | CN101102742A Anti-aging methods and composition |
| 01/09/2008 | CN101102733A Macromolecule-containing sustained release intraocular implants and related methods |
| 01/09/2008 | CN101100766A Preparation of nano fibre carrier for loading and slow releasing pharmaceutical and biologically active factor |
| 01/09/2008 | CN101099868A Material compound for synthesizing norfloxacin macromolecular prodrug with active monomer and preparation method thereof |
| 01/09/2008 | CN101099867A Novel material compound for polyurethane macromolecular prodrug and preparation method |
| 01/09/2008 | CN101099866A Cholesterol copolymer decorated by poloxamer and its application |
| 01/09/2008 | CN101099815A Gynaecologic antibiotic gel and preparation method and application thereof |
| 01/09/2008 | CN101099748A Mussel dextran and its preparation method and application |
| 01/09/2008 | CN101099747A Compound alginic acid chewing tablet and preparation method thereof |
| 01/09/2008 | CN101099742A Testosterone gel preparation capable of decreasing skin irritation |
| 01/09/2008 | CN101099738A Application of sanguinarine in preparing aquatic animal medicine and method for preparing its preparation |
| 01/09/2008 | CN101099735A Wide-spectrum high-efficient microorganism killing agent |
| 01/09/2008 | CN101099733A Taxol freezing-dried emulsion for injection and preparation method thereof |
| 01/09/2008 | CN101099730A Oral solid preparation containing ambroxol hydrochloride and guaifenesin active components |
| 01/09/2008 | CN101099729A Oral solid preparation containing ambroxol hydrochloride and salbutamol active components |
| 01/09/2008 | CN101099728A Mucosa adhesion nanometer particle-aquagel membrane drug delivery system and preparation method thereof |
| 01/09/2008 | CN101099727A Method for preparing microcapsule having function of specific connecting with tumor cell |
| 01/09/2008 | CN101099726A Phentolamine Mesylate freeze-dried powder injection preparation and preparation method thereof |
| 01/09/2008 | CN101099723A New use of taxol-like nano preparation |
| 01/09/2008 | CN100360568C Method for preparing copolymer water dispersing body by hydrophilous and hydrophobic monomer, and obtained copolymer therefrom and application |
| 01/09/2008 | CN100360564C Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 01/09/2008 | CN100360553C Compounds and use thereof to modify transport across cell membranes |
| 01/09/2008 | CN100360181C Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 01/09/2008 | CN100360175C Pharmatceutical Formualtion comprising cyclosporin and use thereof |
| 01/09/2008 | CN100360174C Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (t beta 4), analogues, isoforms and other derivatives |
| 01/09/2008 | CN100360131C Production method of odor-masking enrofloxacin |
| 01/09/2008 | CN100360117C Pharmaceutical compositions with improved dissolution |
| 01/09/2008 | CN100360116C Powder formulations suitable for inhalation |
| 01/09/2008 | CN100360115C Molecular coating method of plant polyphenol kind substance |
| 01/08/2008 | US7317095 Mutant glycoproteins |
| 01/08/2008 | US7317026 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 01/08/2008 | US7317002 Site-specific preparation of polyethylene glycol-GRF conjugates |
| 01/08/2008 | US7316996 For stimulating macrophages, for stimulating antibody synthesis, for combating infection, as an immunostimulant, in particular in relation to tumors, for preventing and treating septicaemic shock, for wound healing and as an adjuvant for vaccines |
| 01/08/2008 | US7316820 Applying an ethoxylated oil (Kayuuputih Eucalyptus oil, macadamia nut oil or meadow foam oil) containing 10-19 ethoxy units/molecule to reducie the appearance a varicose or spider vein or a stretch mark; nonsteroidal antiinflammatory drugs, collagen, skin brighteners (tyrosinase inhibitor) |
| 01/08/2008 | US7316819 Oral peptide pharmaceutical dosage form and method of production |
| 01/08/2008 | US7316818 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 01/08/2008 | US7316816 Temperature and pH sensitive copolymers |
| 01/08/2008 | US7316813 Influenza vaccine composition |
| 01/08/2008 | US7316811 Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles |
| 01/08/2008 | CA2360938C Controlled release composite |
| 01/08/2008 | CA2348474C Pharmaceutically active composition and dispensing device |
| 01/08/2008 | CA2346350C Intraoral quickly disintegrating tablets |
| 01/08/2008 | CA2337885C Enteric coated pharmaceutical tablet and method of manufacturing |
| 01/08/2008 | CA2335079C Composition for the treatement of immune deficiencies and methods for its preparation and use |
| 01/08/2008 | CA2322028C Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders |
| 01/08/2008 | CA2310070C Biodegradable polymer scaffold |
| 01/08/2008 | CA2306824C Encapsulation method |